Record CyPath® Lung Revenue and Unit Sales. Revenue from our noninvasive diagnostic for lung cancer increased 87% over 2024 with the number of tests performed rising 99% year over year, reflecting ...

The MarketWatch News Department was not involved in the creation of this content. Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company's ...

Market OverviewThe global allergy diagnostics market is expected to witness strong growth at a compound annual growth rate of ...

Affinity Technologies, Inc. (NASDAQ:BIAF) released its financial results for the year ended December 31, 2025, according to a ...

Researchers analyzed molecular sensitization patterns in Polish patients with perennial allergic rhinitis who tested positive for cockroach allergens. They found that most apparent cockroach allergies ...

Viral disease like chicken pox, herpes, viral fever (allergic), hepatitis A & E are common these days, according to Dr Ajay ...

Cases of human metapneumovirus are on the rise across the country. Here's what this virus is, plus how to protect yourself.

Chronic obstructive pulmonary disease (COPD) has become one of the world’s most lethal but least prioritised health crises.

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.

No Smoking Day this year feels especially important for Brighton and Hove. Our city has long been known for compassion and ...

Jefferson Health in Philadelphia launched a virtual primary care program in late 2024 to address one of healthcare’s biggest access challenges: a shortage of primary care appointments. Less than two ...